Pursuant to Paragraph 9.20 of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad, Analabs wishes to inform that the aggregate purchase consideration of quoted securities by the Company for the preceding 12 months (excluding the purchase which was previously announced on 6 March 2020 pursuant to Paragraph 9.20), has exceeded 5% of Analabs Group’s audited consolidated net assets as at 30 April 2019, details as follows:-

Aggregate Purchase Consideration within the preceding      :           RM18,550,140

12 months from 7 March 2020 to 13 March 2020                            

% of the Audited Consolidated Net Assets                             :           6.87% 

As at 13 March 2020, the investments in quoted securities held by Analabs Group are set out below:-

1. Total Cost :  RM121,805,324.40
2. Book Value :RM108,615,675.53
3. Market Value : RM98,159,960.63

This announcement is dated 13 March 2020.